(3beta,16alpha)-16-Bromo-3,7-dihydroxyandrost-5-en-17-one | 502848-93-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (3beta,16alpha)-16-Bromo-3,7-dihydroxyandrost-5-en-17-one
• 英文别名: (3S,7R,8R,9S,10R,13S,14S,16R)-16-bromo-3,7-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
• CAS: 502848-93-3
• 化学式: C₁₉H₂₇BrO₃
• 分子量: 383.3
• InChiKey: ZYIKAQWGAUTCMD-ZBZWUMDLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  23
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.84
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
  申请人：Hollis-Eden Pharmaceuticals Inc.

  公开号：EP1422234A2

  公开（公告）日：2004-05-26

  A compound having the structure and said compound can be used for the preparation of a medicament for the enhancement of the numbers or activity of neutrophils or dendritic cells in a human or a primate having or susceptible to developing an innate immune suppression condition.

  具有以下结构的化合物 和所述化合物可用于制备提高人类或灵长类动物中性粒细胞或树突状细胞数量或活性的药物，这些动物患有或易患先天性免疫抑制病症。
• Immune modulation method using steroid compounds
  申请人：——

  公开号：US20030060425A1

  公开（公告）日：2003-03-27

  The invention provides compositions comprising formula 1 steroids, e.g., 16&agr;-bromo-3 &bgr;-hydroxy-5&agr;-androstan-17-one hemihydrate and one or more excipients, including compositions that comprise a liquid formulation comprising less than about 3% v/v water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16&agr;-bromo-3&bgr;-hydroxy-5&agr;-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using the compounds. The invention also provides methods to make and use these immunomodulatory compositions and formulations.

  本发明提供了由式 1 类固醇（如 16&agr;-溴-3&bgr;-羟基-5&agr;-雄甾烷-17-酮半水合物）和一种或多种赋形剂组成的组合物，包括由含水量小于约 3% v/v 的液体制剂组成的组合物。这些组合物可用于制造改进的药物制剂。本发明还提供了类固醇化合物（如 16&agr;-溴-3&bgr;-羟基-5&agr;-雄甾烷-17-酮的类似物）的间歇给药方法和用于此类给药方案的组合物。本发明进一步提供了抑制病原体复制、改善与免疫失调相关的症状以及使用化合物调节受试者免疫反应的组合物和方法。本发明还提供了制造和使用这些免疫调节组合物和制剂的方法。
• IMMUNOMODULATORY STEROIDS, IN PARTICULAR THE HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE
  申请人：Hollis-Eden Pharmaceuticals

  公开号：EP1163256A1

  公开（公告）日：2001-12-19
• [EN] IMMUNOMODULATORY STEROIDS, IN PARTICULAR THE HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE<br/>[FR] STEROIDES IMMUNOMODULATEURS, PLUS SPECIFIQUEMENT LE SEMI-HYDRATE DE 16.ALPHA.-BROMOEPIANDROSTERONE
  申请人：HOLLIS EDEN PHARMACEUTICALS

  公开号：WO2000056757A1

  公开（公告）日：2000-09-28

  The invention provides compositions comprising formula 1 steroids, e.g., 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-one hemihydrate and one or more excipients, typically wherein the composition comprises less than about 3% water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen (viral) replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using certain steroids and steroid analogs. The invention also provides methods to make and use these immunomodulatory compositions and formulations.